These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7728742)

  • 21. Relationship between thromboxane B2 and 6-keto-prostaglandin F1 alpha in sepsis.
    Nakae H; Endo S; Inada K; Takakuwa T; Kasai T; Yoshida M
    Res Commun Chem Pathol Pharmacol; 1994 Mar; 83(3):297-302. PubMed ID: 8008979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects of berberine on platelet aggregation and plasma levels of TXB2 and 6-keto-PGF1 alpha in rats with reversible middle cerebral artery occlusion].
    Wu JF; Liu TP
    Yao Xue Xue Bao; 1995; 30(2):98-102. PubMed ID: 7785438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thromboxane and prostacyclin release during cardiac immediate hypersensitivity reactions in vitro.
    Allan G; Levi R
    J Pharmacol Exp Ther; 1981 Apr; 217(1):157-61. PubMed ID: 6894166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of thiofedrine on platelet aggregation, thromboxane B2 and 6-keto-PGF1 alpha in rats.
    Qu YZ; Wang YE; Li XX
    Methods Find Exp Clin Pharmacol; 1996 Jun; 18(5):297-300. PubMed ID: 8817463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential intracellular target proteins of the anticarcinogenic Bowman Birk protease inhibitor identified by affinity chromatography.
    Billings PC; St Clair W; Owen AJ; Kennedy AR
    Cancer Res; 1988 Apr; 48(7):1798-802. PubMed ID: 3280120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The changes of thromboxane B2 (TXB2) and 6-keto-prostaglandin F1 alpha(6-keto-PGF1 alpha) in the lungs of rats drowned in hypothermic-sea-water].
    Jiang Z; Zhong G; Wang EE; Fan J; Jia G; Lu Q; Yang D
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2002 Feb; 20(1):29-31. PubMed ID: 14694611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Quantitive study of 6-keto-prostaglandin F1 alpha and thromboxane B2 in human pulp].
    Dong Y; Zhou J; Pan Y
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1999 Jul; 34(4):236-8. PubMed ID: 11776916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanomolar concentrations of Bowman-Birk soybean protease inhibitor suppress x-ray-induced transformation in vitro.
    Yavelow J; Collins M; Birk Y; Troll W; Kennedy AR
    Proc Natl Acad Sci U S A; 1985 Aug; 82(16):5395-9. PubMed ID: 3860869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bowman-Birk soybean protease inhibitor as an anticarcinogen.
    Yavelow J; Finlay TH; Kennedy AR; Troll W
    Cancer Res; 1983 May; 43(5 Suppl):2454s-2459s. PubMed ID: 6682011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of taurine enhancement of synthesis of TxA2 and PGI2 in cultured intra-pulmonary arteriolar smooth muscle cells under acute hypoxia].
    Hu DH
    Sheng Li Xue Bao; 1998 Aug; 50(4):465-8. PubMed ID: 11324559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of protease inhibitors on radiation transformation in vitro.
    Kennedy AR; Little JB
    Cancer Res; 1981 Jun; 41(6):2103-8. PubMed ID: 7237415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in 6 keto PGF1 alpha and TXB2 in patients with myocardial infarction.
    Madan ZM; Sainani GS
    J Assoc Physicians India; 1994 Feb; 42(2):111-2. PubMed ID: 7860468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclooxygenase inhibition with acetylsalicylic acid unmasks a role for prostacyclin in erythropoietin-induced hypertension in uremic rats.
    Rodrigue ME; Lacasse-M S; Larivière R; Lebel M
    Can J Physiol Pharmacol; 2005 Jun; 83(6):467-75. PubMed ID: 16049546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Volume-induced natriuresis in healthy women: renal metabolism of prostacyclin and thromboxane, and physiological role of prostanoids.
    Agnoli GC; Borgatti R; Cacciari M; Lenzi P; Marinelli M; Stipo L
    Prostaglandins Leukot Essent Fatty Acids; 2001 Feb; 64(2):95-103. PubMed ID: 11237476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improvement of renal function with a selective thromboxane A2 synthetase inhibitor, DP-1904, in lupus nephritis.
    Yoshida T; Kameda H; Ichikawa Y; Tojo T; Homma M
    J Rheumatol; 1996 Oct; 23(10):1719-24. PubMed ID: 8895147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of 3-methylcholanthrene-induced cellular transformation by timed administration of the Bowman-Birk protease inhibitor.
    St Clair WH
    Carcinogenesis; 1991 May; 12(5):935-7. PubMed ID: 2029760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of acetylsalvianolic acid A on arachidonic acid metabolism in platelets].
    Yu W; Xu L
    Yao Xue Xue Bao; 1998; 33(1):62-3. PubMed ID: 11938938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A serine protease activity in C3H/10T1/2 cells that is inhibited by anticarcinogenic protease inhibitors.
    Billings PC; Carew JA; Keller-McGandy CE; Goldberg AL; Kennedy AR
    Proc Natl Acad Sci U S A; 1987 Jul; 84(14):4801-5. PubMed ID: 3299374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bowman-Birk protease inhibitor activates DNA-dependent protein kinase and reduces formation of radiation-induced dicentric chromosomes.
    Dittmann K; Virsik-Köpp P; Mayer C; Rave-Fränk M; Rodemann HP
    Int J Radiat Biol; 2003 Oct; 79(10):801-8. PubMed ID: 14630539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Changes of prostaglandins in kidney tissue in gentamicin-induced acute renal tubular injury in rats].
    Yu Y; Zheng F; Bo Y; Duan J; Huang H
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Feb; 20(1):38-43. PubMed ID: 11367732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.